Memorial Sloan Kettering Commack (All protocol activities)

Running trials

• Active, not recruiting

  A Study of Minimally Invasive Proximal Gastrectomy Versus Minimally Invasive Total Gastrectomy for Gastric and Gastroesophageal Junction Cancers

  NCT06243757· Source

• Recruiting

  A Study of Short-Course Radiation Therapy With Chemotherapy in People With Endometrial Cancer

  NCT05691010· Early phase 1· Source

• Active, not recruiting

  A Study on Limiting Treatment Time With Acalabrutinib Combined With Obinutuzumab in People With CLL or SLL

  NCT04722172· Phase 2· Source

• Recruiting

  Radiation and TSR-042 (Dostarlimab) in People With Endometrial Cancer After They Receive Surgery

  NCT04774419· Phase 2· Source

• Active, not recruiting

  A Study of Nivolumab Combined With FOLFOX and Regorafenib in People Who Have HER2-Negative Esophagogastric Cancer

  NCT04757363· Phase 2· Source

• Active, not recruiting

  The Combination of Venetoclax and Obinutuzumab in People With Chronic Lymphocytic Leukemia (CLL)

  NCT04447768· Phase 2· Source

• Active, not recruiting

  Measuring Cell-Free DNA (cfDNA) Levels in People With Follicular Lymphoma

  NCT04468841· Phase 1· Source

• Active, not recruiting

  Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax

  NCT04419519· Phase 2· Source

• Recruiting

  Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

  NCT04291612· Source

• Active, not recruiting

  Dose Reduction of Postoperative Radiation for Soft Tissue Sarcoma of the Arms and Legs

  NCT04288375· Phase 2· Source

• Active, not recruiting

  Pembrolizumab (MK-3475) and Bacillus Calmette-Guérin (BCG) as First-Line Treatment for High-Risk T1 Non-Muscle-Invasive Bladder Cancer (NMIBC) and High-Grade Non-Muscle-Invasive Upper Tract Urothelial Carcinoma (NMI-UTUC)]

  NCT03504163· Phase 2· Source

• Active, not recruiting

  A Study to Test the Safety of Immunotherapy With Nivolumab Alone or With Ipilimumab Before Surgery for Bladder Cancer Patients Who Are Not Suitable for Chemotherapy

  NCT03520491· Phase 2· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Endometrial cancer3 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Radiation Therapy to Relieve Symptoms in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

  NCT04384146· Phase 1· Source

• Completed

  Study of Nutritional Supplement Shakes in People About to Receive Their Debulking Surgery for Ovarian Cancer

  NCT03956095· Source